ProCE Banner Activity

Emergence of Resistance Mutations in People Living With HIV Receiving Second-Generation INSTIs

Conference Coverage

This study reports subsequent INSTI resistance associated mutations, including the R263K mutant, among people living with HIV who experienced treatment failure after receiving second generation INSTI-based ART.

Released: March 11, 2024

Expiration: March 10, 2025


Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


This activity is supported through independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare